MedTrace Logo

Affirmative Family and Individual Psychotherapy for Sexual and Gender Minority Adults and Their Nonaccepting Parents

NCT05766592 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2026-01-13

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of an LGBTQ-affirmative individual cognitive behavioral psychotherapy (CBT) and LGBTQ-affirmative family therapy (attachment-based family therapy for sexual and gender minority young adults; ABFT-SGM) delivered via telehealth to a sample of sexual and gender minority adults with nonaccepting parent(s) in New York, Pennsylvania, Connecticut, and Israel. The investigators will assess whether both treatments are associated with significant decreases in depressive and anxiety symptoms. The investigators will also assess whether and how each treatment achieves reductions in mental health symptoms through specific mechanisms (e.g., rejection sensitivity, internalized stigma, emotion dysregulation, parental rejection and acceptance).

Conditions

  • Mental Health Issue
  • Parent-Child Relations

Interventions

BEHAVIORAL

LGBTQ-affirmative CBT

16-session LGBTQ-affirmative psychotherapy using cognitive behavioral techniques

BEHAVIORAL

ABFT-SGM

16-session attachment-based family therapy for sexual and gender minority young adults and their nonaccepting parents

Sponsors & Collaborators

  • Ben-Gurion University of the Negev

    collaborator OTHER

  • Israel Science Foundation

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • John E Pachankis, PhD · Yale University

  • Gary M Diamond, PhD · Ben-Gurion University of the Negev

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-13
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05766592 on ClinicalTrials.gov